Evidence map›Paper›PMID 40260863›Full record

ArticleJournal of cell science2025

Nanobodies against Cavin1 reveal structural flexibility and regulated interactions of its N-terminal coiled-coil domain.

Ya Gao, Vikas A Tillu, Yeping Wu, James Rae, Thomas E Hall, Kai-En Chen, Saroja Weeratunga, Qian Guo, Emma Livingstone, Wai-Hong Tham and 2 more

Abstract read
In one paragraph

Article in Journal of cell science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Caveolae mechanics in cellular functions and disease.Nature reviews. Molecular cell biology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ya GaoInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Vikas A TilluInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Yeping WuInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
James RaeInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Thomas E HallInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Kai-En ChenInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Saroja WeeratungaInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Qian GuoInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Emma LivingstoneInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Wai-Hong ThamInfectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
Robert G PartonInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.
Brett M CollinsInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland 4067, Australia.ORCID 0000-0002-6070-3774

Funding

Australian Research Council FL210100107National Health and Medical Research Council APP2016410University of Queensland
6 · The paper itself

Abstract

Caveolae are abundant plasma membrane structures that regulate signalling, membrane homeostasis and mechanoprotection. Their formation is driven by caveolins and cavins and their coordinated interactions with lipids. Here, we developed nanobodies against the trimeric HR1 coiled-coil domain of Cavin1. We identified specific nanobodies that do not perturb Cavin1 membrane binding and localise to caveolae when expressed in cells. The crystal structure of a nanobody-Cavin 1 HR1 complex reveals a symmetric 3:3 architecture as validated by mutagenesis. In this structure, the C-terminal half of the HR1 domain is disordered, suggesting that the nanobody stabilises an open conformation of Cavin1, which has previously been identified as important for membrane interactions. A phosphomimic mutation in a threonine-serine pair proximal to this region reveals selective regulation of Cavin2 and Cavin3 association. These studies provide new insights into cavin domains required for assembly of multiprotein caveolar assemblies and describe new nanobody tools for structural and functional studies of caveolae.

Indexed as

RNA-Binding ProteinsSingle-Domain AntibodiesAnimalsCaveolaeHEK293 CellsHumansModels, MolecularProtein BindingProtein DomainsCAVIN1 protein, humanRNA-Binding ProteinsSingle-Domain AntibodiesCaveolaeCaveolinCavinNanobodyPTRF

Identifiers

PMID40260863
PMCPMC12079668

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.